Back to Search
Start Over
[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions.
- Source :
- British Journal of Haematology; Jun2018, Vol. 181 Issue 5, p701-703, 3p, 1 Black and White Photograph, 1 Chart
- Publication Year :
- 2018
-
Abstract
- The article discusses a prospective study which investigated the emergence of L-methyl-C methionine (MET) as a new biomarker for monitoring active myeloma lesions. Involved in the study were ten patients with biopsy-proven multiple myeloma who underwent molecular imaging using positron emission tomography (PET) with a radiolabelled glucose analogue for diagnosis. The study has shown the potential superiority of the amino acid MET for staging multiple myeloma.
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 181
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 129857319
- Full Text :
- https://doi.org/10.1111/bjh.14696